Trademarks = 4

Forward Citations = 4

Loading Chart...

5 inventors (with patents filed for the assignee):

Laura Deveau (3 out of 3 patents)

Jonathan Belk (3 out of 21 patents)

C Garrett Rappazzo (3 out of 3 patents)

4. Anna Z Wec (3 out of 14 patents)

5. Laura M Walker (3 out of 24 patents)

3 patents: Sort by Forward Citations

1. 11414479 - Compounds specific to coronavirus S protein and uses thereof (2022-08-16),

2. 11220536 - Compounds specific to coronavirus S protein and uses thereof (2022-01-11),

3. 11192940 - Compounds specific to coronavirus S protein and uses thereof (2021-12-07),

Company Overview

Adagio Therapeutics is a biotechnology company focused on the discovery and development of antibody-based therapies for infectious and inflammatory diseases. Their proprietary platform enables the rapid generation of novel antibodies with superior potency and specificity. Adagio is committed to advancing its pipeline of innovative therapies to address unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

3 Patents

#230 in Waltham, MA

#3,964 in Massachusetts

#73,904 in US

Waltham, MA, United States of America

Adagio Therapeutics, Inc.

Forward Citations = 4

5 inventors:

Laura Deveau (3 out of 3 patents)

Jonathan Belk (3 out of 21 patents)

C Garrett Rappazzo (3 out of 3 patents)

4. Anna Z Wec (3 out of 14 patents)

5. Laura M Walker (3 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Adagio Therapeutics, Inc.. Retrieved from https://idiyas.com/company/adagio-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]